These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24642358)

  • 41. Plasma Urotensin II levels in children and adolescents with chronic kidney disease: a single-centre study.
    Garoufi A; Drapanioti S; Marmarinos A; Askiti V; Mitsioni AJ; Mila M; Grigoriadou G; Georgakopoulos D; Stefanidis CJ; Gourgiotis D
    BMC Nephrol; 2017 Mar; 18(1):113. PubMed ID: 28359257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Body mass and atherogenic dyslipidemia as major determinants of blood levels of B-type natriuretic peptides in Arab subjects with acute coronary syndromes.
    Akanji AO; Suresh CG; Al-Radwan R; Fatania HR
    Metab Syndr Relat Disord; 2009 Dec; 7(6):563-9. PubMed ID: 19642911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urotensin II receptor expression in human right atrium and aorta: effects of ischaemic heart disease.
    Leonard AD; Thompson JP; Hutchinson EL; Young SP; McDonald J; Swanevelder J; Lambert DG
    Br J Anaesth; 2009 Apr; 102(4):477-84. PubMed ID: 19258379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease--KOZANI STUDY.
    Kadoglou NP; Lampropoulos S; Kapelouzou A; Gkontopoulos A; Theofilogiannakos EK; Fotiadis G; Kottas G
    Transl Res; 2010 May; 155(5):238-46. PubMed ID: 20403579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic and pharmacological manipulation of urotensin II ameliorate the metabolic and atherosclerosis sequalae in mice.
    You Z; Genest J; Barrette PO; Hafiane A; Behm DJ; D'Orleans-Juste P; Schwertani AG
    Arterioscler Thromb Vasc Biol; 2012 Aug; 32(8):1809-16. PubMed ID: 22723440
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does cigarette smoking increase plasma urotensin II concentrations?
    Gold SJ; Thompson JP; Williams JP; Helm EE; Sadler J; Song W; Ng LL; Lambert DG
    Eur J Clin Pharmacol; 2007 Mar; 63(3):253-7. PubMed ID: 17252242
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Measurement of oxidized lipoprotein (a) in patients with acute coronary syndromes and stable coronary artery disease by 2 ELISAs: using different capture antibody against oxidized lipoprotein (a) or oxidized LDL.
    Wang JJ; Han AZ; Meng Y; Gong JB; Zhang CN; Li K; Liu YX
    Clin Biochem; 2010 Apr; 43(6):571-5. PubMed ID: 20060390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serial changes in plasma levels of cytokines in patients with coronary artery disease.
    Heinisch RH; Zanetti CR; Comin F; Fernandes JL; Ramires JA; Serrano CV
    Vasc Health Risk Manag; 2005; 1(3):245-50. PubMed ID: 17319110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical significance of increased urotensin II levels in acute myocardial infarction.
    Zhang X; Ye Y; Yang C; Gong H; Li Y; Zhang G; Yuan J; Zou Y
    Discov Med; 2018 Aug; 26(141):7-20. PubMed ID: 30265851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Total and high molecular weight adiponectin in patients with coronary artery disease.
    El-Menyar A; Rizk N; Al Nabti AD; Hassira SA; Singh R; Abdel Rahman MO; Suwaidi JA
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):310-5. PubMed ID: 19430341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urotensin II levels in patients with inflammatory bowel disease.
    Alicic D; Martinovic D; Rusic D; Zivkovic PM; Tadin Hadjina I; Vilovic M; Kumric M; Tokic D; Supe-Domic D; Lupi-Ferandin S; Bozic J
    World J Gastroenterol; 2021 Sep; 27(36):6142-6153. PubMed ID: 34629825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urotensin II, from fish to human.
    Vaudry H; Do Rego JC; Le Mevel JC; Chatenet D; Tostivint H; Fournier A; Tonon MC; Pelletier G; Conlon JM; Leprince J
    Ann N Y Acad Sci; 2010 Jul; 1200():53-66. PubMed ID: 20633133
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans.
    Liu SW; Qiao SB; Yuan JS; Liu DQ
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):202-7. PubMed ID: 19178507
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulating levels of TNF-like cytokine 1A correlate with reflected waves and atherosclerosis extent and may predict cardiac death in patients with stable coronary artery disease.
    Stamatelopoulos K; Georgiou S; Kanakakis I; Papamichael C; Oikonomidis N; Mantzou A; Samouilidou E; Loizos S; Zakopoulos N; Sfikakis PP
    Cytokine; 2015 Mar; 72(1):102-4. PubMed ID: 25563533
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum osteoprotegerin and carotid intima-media thickness in acute/chronic coronary artery diseases.
    Ciccone MM; Scicchitano P; Gesualdo M; Zito A; Carbonara R; Locorotondo M; Mandurino C; Masi F; Boccalini F; Lepera ME
    J Cardiovasc Med (Hagerstown); 2013 Jan; 14(1):43-8. PubMed ID: 22772598
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunolocalization of urotensin II and its receptor in human adrenal tumors and attached non-neoplastic adrenal tissues.
    Morimoto R; Satoh F; Murakami O; Totsune K; Arai Y; Suzuki T; Sasano H; Ito S; Takahashi K
    Peptides; 2008 May; 29(5):873-80. PubMed ID: 17686550
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated expression of urotensin II and its receptor in diabetic cardiomyopathy.
    Dai HY; Guo XG; Ge ZM; Li ZH; Yu XJ; Tang MX; Zhang Y
    J Diabetes Complications; 2008; 22(2):137-43. PubMed ID: 18280445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
    Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
    Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease.
    Hung MJ; Cherng WJ; Cheng CW; Li LF
    Am J Cardiol; 2006 May; 97(10):1429-34. PubMed ID: 16679078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Expression of urotensinII in human coronary artery and coronary atherosclerosis].
    Tu XW; Liu YF; Li ZL; Wu HC; Lu Q; Tang CS
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Jun; 23(6):572-4. PubMed ID: 12810379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.